Bioxytran annual gross profit
2010
2011
2012
2013
2014
2015
2016
2017
Bioxytran Gross Profit Growth & History (BIXT)
Bioxytran's gross profit was $87,098 for fiscal 2017.
View full Bioxytran company overviewBioxytran annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2017 | 2017-12-31 | $87,098 | −$63,093 | −42.01% |
| 2016 | 2016-12-31 | $150,191 | $30,054 | +25.02% |
| 2015 | 2015-12-31 | $120,137 | $10,498 | +9.58% |
| 2014 | 2014-12-31 | $109,639 | −$110,306 | −50.15% |
| 2013 | 2013-12-31 | $219,945 | $28,961 | +15.16% |
| 2012 | 2012-12-31 | $190,984 | $133,763 | +233.77% |
| 2011 | 2011-12-31 | $57,221 | $45,123 | +372.98% |
| 2010 | 2010-12-31 | $12,098 | — | — |
Bioxytran quarterly gross profit
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2018 | 2018-06-30 | $12,195 | −$7,881 | −39.26% |
| Q1 2018 | 2018-03-31 | −$1,933 | $4,304 | — |
| Q4 2017 | 2017-12-31 | −$6,831 | −$42,562 | — |
| Q3 2017 | 2017-09-30 | $80,090 | $17,150 | +27.25% |
| Q2 2017 | 2017-06-30 | $20,076 | −$16,725 | −45.45% |
| Q1 2017 | 2017-03-31 | −$6,237 | −$20,956 | — |
| Q4 2016 | 2016-12-31 | $35,731 | $51,200 | — |
| Q3 2016 | 2016-09-30 | $62,940 | $19,952 | +46.41% |
| Q2 2016 | 2016-06-30 | $36,801 | −$7,875 | −17.63% |
| Q1 2016 | 2016-03-31 | $14,719 | −$33,223 | −69.30% |
| Q4 2015 | 2015-12-31 | −$15,469 | $62,082 | — |
| Q3 2015 | 2015-09-30 | $42,988 | $35,799 | +497.97% |
| Q2 2015 | 2015-06-30 | $44,676 | $18,833 | +72.87% |
| Q1 2015 | 2015-03-31 | $47,942 | −$106,216 | −68.90% |
| Q4 2014 | 2014-12-31 | −$77,551 | −$123,791 | — |
| Q3 2014 | 2014-09-30 | $7,189 | −$7,323 | −50.46% |
| Q2 2014 | 2014-06-30 | $25,843 | −$29,435 | −53.25% |
| Q1 2014 | 2014-03-31 | $154,158 | $50,243 | +48.35% |
| Q4 2013 | 2013-12-31 | $46,240 | −$854 | −1.81% |
| Q3 2013 | 2013-09-30 | $14,512 | $50,030 | — |
| Q2 2013 | 2013-06-30 | $55,278 | −$28,637 | −34.13% |
| Q1 2013 | 2013-03-31 | $103,915 | $8,422 | +8.82% |
| Q4 2012 | 2012-12-31 | $47,094 | $29,785 | +172.08% |
| Q3 2012 | 2012-09-30 | −$35,518 | −$45,417 | — |
| Q2 2012 | 2012-06-30 | $83,915 | $59,850 | +248.70% |
| Q1 2012 | 2012-03-31 | $95,493 | $89,545 | +1505.46% |
| Q4 2011 | 2011-12-31 | $17,309 | — | — |
| Q3 2011 | 2011-09-30 | $9,899 | $8,557 | +637.63% |
| Q2 2011 | 2011-06-30 | $24,065 | $19,207 | +395.37% |
| Q1 2011 | 2011-03-31 | $5,948 | — | — |
| Q3 2010 | 2010-09-30 | $1,342 | — | — |
| Q2 2010 | 2010-06-30 | $4,858 | — | — |
Bioxytran gross profit trends
Over the last five fiscal years, Bioxytran's gross profit decreased from $190,984 to $87,098, a change of −$103,886. The latest reported quarter, Q2 2018, shows $12,195.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioxytran source filings ↗